Absci joins Oracle and AMD for AI-led drug discovery (ABSI)
rafal_olechowski
Absci (NASDAQ:ABSI) on Thursday announced a collaboration with Oracle Cloud Infrastructure (NYSE:ORCL) and AMD (NASDAQ:AMD) to accelerate its AI-driven drug discovery efforts.
As part of the partnership, the Vancouver, Washington-based biotech will use Oracleâs (NYSE:ORCL) AI infrastructure and AMDâs (
Recommended For You
关于《Absci joins Oracle and AMD for AI-led drug discovery (ABSI)》的评论
暂无评论
发表评论
摘要
Absci (NASDAQ:ABSI) has partnered with Oracle Cloud Infrastructure (NYSE:ORCL) and AMD (NASDAQ:AMD) to speed up its AI-driven drug discovery process, utilizing Oracle's AI infrastructure and AMD's technology.